Amgen Inc. (AMGN) FY2025 Q3 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2025-07-01 to 2025-09-30

Swipe to see the full flow
Amgen Inc. cash flow reconciliation, Jul 1, 2025 through Sep 30, 2025One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $3,216,000,000.00Depreciation, amortization and other → Operating adjustments reconciliation: $1,307,000,000.00Accrued sales incentives and allowance → Operating adjustments reconciliation: $1,184,000,000.00Accrued income taxes, net → Operating adjustments reconciliation: $610,000,000.00Impairment of intangible assets → Operating adjustments reconciliation: $400,000,000.00Inventories → Operating adjustments reconciliation: $240,000,000.00Trade receivables, net → Operating adjustments reconciliation: $222,000,000.00Stock-based compensation expense → Operating adjustments reconciliation: $127,000,000.00Long-term tax liabilities → Operating adjustments reconciliation: $74,000,000.00Operating adjustments reconciliation → Net cash from operating activities: $1,468,000,000.00Operating adjustments reconciliation → Gains on equity securities: $1,971,000,000.00Operating adjustments reconciliation → Other assets: $283,000,000.00Operating adjustments reconciliation → Accrued liabilities: $200,000,000.00Operating adjustments reconciliation → Accounts payable: $174,000,000.00Operating adjustments reconciliation → Deferred income taxes: $30,000,000.00Operating adjustments reconciliation → Other items, net: $28,000,000.00Operating adjustments reconciliation → Other liabilities: $10,000,000.00Other → investing reconciliation: $22,000,000.00Net cash used in investing activities → investing reconciliation: $414,000,000.00investing reconciliation → Purchases of property, plant and equipment: $436,000,000.00Net cash used in financing activities → financing reconciliation: $2,853,000,000.00Other → financing reconciliation: $10,000,000.00financing reconciliation → Repayment of debt: $1,500,000,000.00financing reconciliation → Dividends paid: $1,282,000,000.00financing reconciliation → Extinguishment of debt: $81,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $8,028,000,000.00Net cash from operating activities → Cash sources and uses: $4,684,000,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $9,445,000,000.00Cash sources and uses → Net cash used in investing activities: $414,000,000.00Cash sources and uses → Net cash used in financing activities: $2,853,000,000.00Net income: $3,216,000,000.00Net income+$3.22 BDepreciation, amortization and other: $1,307,000,000.00Depreciation & amortization+$1.31 BImpairment of intangible assets: $400,000,000.00Intangible impairments+$400.00 MStock-based compensation expense: $127,000,000.00Stock-based compensation+$127.00 MDeferred income taxes: -$30,000,000.00Deferred taxes & credits−$30.00 MGains on equity securities: -$1,971,000,000.00Investment value change−$1.97 BOther items, net: -$28,000,000.00Other non-cash items−$28.00 MTrade receivables, net: $222,000,000.00Accounts receivable+$222.00 MInventories: $240,000,000.00Inventories+$240.00 MOther assets: -$283,000,000.00Other operating assets−$283.00 MAccounts payable: -$174,000,000.00Accounts payable−$174.00 MAccrued income taxes, net: $610,000,000.00Income taxes payable+$610.00 MLong-term tax liabilities: $74,000,000.00Long-term tax liabilities+$74.00 MAccrued liabilities: -$200,000,000.00Accrued liabilities−$200.00 MAccrued sales incentives and allowance: $1,184,000,000.00Accrued sales incentives and allowance+$1.18 BOther liabilities: -$10,000,000.00Other operating liabilities−$10.00 MNet cash from operating activities: $4,684,000,000.00Operating cash+$4.68 BOperating adjustments reconciliation: $4,164,000,000.00Extinguishment of debt: -$81,000,000.00Debt extinguishment costs−$81.00 MRepayment of debt: -$1,500,000,000.00Long-term debt repaid−$1.50 BDividends paid: -$1,282,000,000.00Common dividends paid−$1.28 BOther: $10,000,000.00Other financing, net+$10.00 MNet cash used in financing activities: -$2,853,000,000.00. Cash required to fund net payments.Financing cash−$2.85 Bfinancing reconciliation: $2,863,000,000.00Purchases of property, plant and equipment: -$436,000,000.00PP&E purchases−$436.00 MOther: $22,000,000.00Other investing, net+$22.00 MNet cash used in investing activities: -$414,000,000.00. Cash required to fund net payments.Investing cash−$414.00 Minvesting reconciliation: $436,000,000.00Cash sources and uses: $12,712,000,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $8,028,000,000.00Beginning cash$8.03 BEnding cash: Cash, cash equivalents, and restricted cash: $9,445,000,000.00Ending cash$9.45 BCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$4.25 BOperating cash − cash spent on PP&ECash flow / Net income1.46×Operating cash flow ÷ net incomeNet cash change+$1.42 BEnding cash − beginning cash
Chart details

Amgen Inc. cash flow reconciliation, Jul 1, 2025 through Sep 30, 2025

Cash flows for Jul 1, 2025 through Sep 30, 2025. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Jun 30, 2025. Ending cash: Sep 30, 2025. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Jun 30, 2025
8,028,000,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
4,684,000,000 US dollars. Net cash provided.
Net income
3,216,000,000 US dollars
Depreciation, amortization and other
1,307,000,000 US dollars
Impairment of intangible assets
400,000,000 US dollars
Stock-based compensation expense
127,000,000 US dollars
Deferred income taxes
negative 30,000,000 US dollars
Gains on equity securities
negative 1,971,000,000 US dollars
Other items, net
negative 28,000,000 US dollars
Trade receivables, net
222,000,000 US dollars
Inventories
240,000,000 US dollars
Other assets
negative 283,000,000 US dollars
Accounts payable
negative 174,000,000 US dollars
Accrued income taxes, net
610,000,000 US dollars
Long-term tax liabilities
74,000,000 US dollars
Accrued liabilities
negative 200,000,000 US dollars
Accrued sales incentives and allowance
1,184,000,000 US dollars
Other liabilities
negative 10,000,000 US dollars
Investing activities
negative 414,000,000 US dollars. Net cash used.
Purchases of property, plant and equipment
negative 436,000,000 US dollars
Other
22,000,000 US dollars
Financing activities
negative 2,853,000,000 US dollars. Net cash used.
Extinguishment of debt
negative 81,000,000 US dollars
Repayment of debt
negative 1,500,000,000 US dollars
Dividends paid
negative 1,282,000,000 US dollars
Other
10,000,000 US dollars
Operating adjustment reconciliation
4,164,000,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
2,863,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
436,000,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Sep 30, 2025
9,445,000,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
12,712,000,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
1,417,000,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
1.46×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
4,684,000,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
436,000,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
4,248,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $1.47B after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 4,684,000,000 US dollars minus 436,000,000 US dollars equals 4,248,000,000 US dollars.
Amgen Inc. (AMGN) FY2025 Q3 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!